BioImage A/S

BioImage A/S is a drug discovery company based in Copenhagen. Using its unique RedistributionTM platform technology it can track protein translocations in living cells.

Protein translocations are often associated with activation or inactivation of important signalling pathways within a cell. BioImage A/S aims at discovering small molecule drugs that exert their action by modulating protein translocation.

BioImage sold a preclinical cancer compound to TopoTarget and its assay business to Fisher Biosciences during 2006.

Visit BioImage